The resources on this page are offered by Bristol Myers Squibb to assist U.S. healthcare professionals in caring for patients and conducting research with BMS medicines.
BMS Access Support® for patients & caregivers. Find coverage, financial support, medication access, and educational resources.
Login to access Bristol Myers Squibb's resources and services securely with your BMS User ID and Password.
From the scientists behind the microscope to the analysts behind the data, everyone at BMS is working to make an impact. And while our work transforms the lives of patients, it also transforms the lives and careers of our people.
Bristol-Myers Squibb (BMS) has signed a long-term agreement with Samsung BioLogics that will see the Korean firm manufacture one of its antibody cancer drugs. Technology transfer and trial production ...
Fierce Biotech: BMS calls time on Zymeworks collab, ending work on phase 1 cancer bispecific
BMS calls time on Zymeworks collab, ending work on phase 1 cancer bispecific
Five immunology assets in-licensed from BMS with potential to address unmet needs for patients with autoimmune diseases, including late-stage asset for lupus Bain Capital leads $300 million financing ...
FierceBiotech: BMS ditches TIGIT, walking away from $200M bet on Agenus bispecific
STAT: BMS, looking to build a market for a heart drug, turns to a Viz.ai algorithm to detect disease
BMS, looking to build a market for a heart drug, turns to a Viz.ai algorithm to detect disease
FiercePharma: BMS buys Mirati for up to $5.8B as I-O giant branches out
BMS buys Mirati for up to $5.8B as I-O giant branches out
Fierce Pharma: BMS 'well prepared' for Camzyos competition as revenue from new products overtakes legacy portfolio